Abstract

ARISTIZABAL, Julián M. et al. Those "other" bradycardias. Rev. Colomb. Cardiol. [online]. 2015, vol.22, n.6, pp.298-304. ISSN 0120-5633.  https://doi.org/10.1016/j.rccar.2015.07.006.

Bradycardia is a common finding in the context of hospitalized patients. Sometimes it is incidentally detected and its clinical implications are minimized. But sometimes it is associated with the presence of symptoms or hemodynamic compromise in patients who warrant further intervention. The etiology of the bradycardia is not always easy to determine and it is not surprising that many studies are initiated in order to clarify the reason for the situation. Clinicians are familiar with the pharmacological and adverse effects of various drugs we use every day. Despite this, there are many drugs with potential to develop bradycardia in response to a less known pharmacological properties or effects related to rare but certainly significant effects. The aim of this review is to explain the pharmacological properties and clinical impact of some substances that have been associated with bradycardia, beyond which we all know, in order to target interventions to be performed in patients with pharmacological and reversible causes of bradycardia.

Keywords : Arrhythmias; Pharmacology; Sinoatrial node.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )